WebOct 11, 2024 · QIVc + aQIV resulted in lower bed occupancy which, while not substantial, may be critical in very high hospital resource usage situations. ... Seqirus has manufactured and marketed QIVc since the 2024–2024 influenza season. This analysis was funded by Seqirus USA Inc. References. Centers for Disease Control and Prevention (CDC). Flu ... WebDec 9, 2024 · The study analyzed administrative claims data in the U.S. (IQVIA PharMetrics® Plus). 2 Results indicate that, after adjustment for confounders, QIVc was significantly more effective in reducing ...
Seqirus Presents New Phase 3 Clinical Data Supporting Use of ... - BioSpace
WebMay 4, 2024 · New Phase III data shows Seqirus’ cell-based quadrivalent seasonal influenza vaccine (QIVc) was as safe and immunogenic as a standard quadrivalent seasonal influenza vaccine (QIV) in children six months through over four years of age during the US 2024/20 influenza season. The data was presented at the Pediatric Academic Society … WebJul 30, 2024 · SUMMIT, N.J., July 30, 2024 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), presented findings from a new observational safety study conducted in the U.S. that found no unexpected adverse pregnancy outcomes in pregnant people who were vaccinated with the company's cell … sprintf performance
Cell-based Quadrivalent Influenza Vaccine (Surface Antigen
WebDec 9, 2024 · Seqirus currently operates a state-of-the-art cell-based manufacturing facility in Holly Springs, NC, purpose-built in partnership with the U.S. Biomedical Advanced … WebSep 7, 2024 · Flu vaccines available for the 2024 to 2024 season: Eligible groups aged 2 and 3 years on 31 August 2024 school aged children (all primary school aged children … WebJul 2, 2024 · Seqirus UK Limited Address The Point, 29 Market Street, Maidenhead, SL6 8AA, UK WWW http://www.seqirus.com Telephone +44 (0)1628 641 500 Medical Information Direct Line +44 (0) 1748 828816 Medical Information e-mail [email protected] Customer Care direct line 08457 451 500 Product … sprint forward plans